Petrus J de Vries Selected Research

Tuberous Sclerosis (Bourneville's Disease)

1/2022	Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem).
1/2022	The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.
12/2021	Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3.
10/2021	Multivariate data analysis identifies natural clusters of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND).
10/2021	Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.
1/2021	TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex.
1/2021	mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus.
1/2021	Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
1/2021	Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry.
1/2020	Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Petrus J de Vries Research Topics

Disease

49	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 02/2007
16	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 02/2007
13	Seizures (Absence Seizure) 12/2021 - 08/2007
10	Angiomyolipoma 01/2020 - 06/2011
8	Epilepsy (Aura) 12/2021 - 05/2011
8	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2013
7	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019 - 01/2008
3	Autism Spectrum Disorder 01/2021 - 01/2014
2	Neoplasms (Cancer) 01/2021 - 01/2016
2	Rare Diseases (Rare Disease) 01/2021 - 11/2014
2	Infantile Spasms (West Syndrome) 01/2021 - 03/2019
2	Hemorrhage 01/2017 - 01/2016
2	Stomatitis 03/2013 - 01/2013
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 05/2011 - 07/2010
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Autistic Disorder (Autism) 08/2017
1	Rhabdomyoma 01/2017
1	Flank Pain 01/2017
1	Angiofibroma 01/2017
1	Hydrocephalus (Hydrocephaly) 01/2016
1	Disease Progression 03/2013
1	Nasopharyngitis 03/2013
1	Acne Vulgaris 03/2013
1	Fever (Fevers) 01/2013
1	LEOPARD Syndrome (Syndrome, LEOPARD) 05/2011
1	Status Epilepticus (Complex Partial Status Epilepticus) 05/2011
1	Tuberous Sclerosis 1 06/2010
1	Intellectual Disability (Idiocy) 02/2007

Drug/Important Bio-Agent (IBA)

40	trans-sodium crocetinate (crocetin)IBA 01/2022 - 02/2007
14	Everolimus FDA Link 12/2021 - 01/2013
9	TOR Serine-Threonine KinasesIBA 01/2021 - 05/2011
5	MTOR InhibitorsIBA 03/2019 - 07/2015
5	Proteins (Proteins, Gene)FDA Link 12/2015 - 08/2007
4	Sirolimus (Rapamycin)FDA Link 03/2013 - 01/2008
3	lipoarabinomannan (LAM)IBA 01/2019 - 06/2011
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 10/2016
2	Tuberous Sclerosis Complex 2 ProteinIBA 06/2010 - 08/2007
1	Vigabatrin FDA Link 01/2021
1	SteroidsIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 03/2019
1	Aminobutyrates (Aminobutyric Acid)IBA 03/2019
1	adriamycin-14-valerate (AD 48)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2011
1	Kainic Acid (Kainate)IBA 05/2011
1	TensinsIBA 07/2010
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2010
1	Tuberous Sclerosis Complex 1 ProteinIBA 08/2007

Therapy/Procedure

7	Therapeutics 12/2021 - 01/2008
1	Nephrectomy 01/2017